CHDR1514 - Data Repository.xlsx

Data from the CHDR1514 clinical trial titled "A randomized, double-blind, placebo-controlled study to investigate the effects of recombinant human erythropoietin (NeoRecormon) on cycling performance and the occurrence of adverse events in well-trained cyclists.". In the datafile each row is one measurement. Lactate values per subject, per maximal exercise test, per exercise intensity is reported. Average power output for the submaximal exercise test (Time Trial) and road race are also reported.

Legend:
Protocol = Protocol number
SubjectNr = Subject number
ProtTime = Protocol time (zero point is first dosing)
ExpDelta = Expected delta time in minutes (zero point is first dosing)
Activity = Performed activity
Activity_Notes_N = Notes to the activity
Parameter = Measured parameter
Parameter_description = Description of the parameter
Value = Measured value
Unit = Unit of the value
Parameter_Notes_N = Notes to the parameter
LactMax = Lactate measurements belonging to maximal exercise test
ExercSubmax = Submaximal exercise test, or Time trial test
Race = Road race